Caricamento...
Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
Although cisplatin is one of the most common antineoplastic drug, its successful utilisation in cancer treatment is limited by the drug resistance. Multiple attempts have been made to find potential cisplatin chemosensitisers which would overcome cancer cells resistance thus improving antineoplastic...
Salvato in:
| Pubblicato in: | Invest New Drugs |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960624/ https://ncbi.nlm.nih.gov/pubmed/33159673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-020-01032-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|